What is included with this book?
A Word About This Guide | p. viii |
Contributors to the Fifth Edition | p. x |
Acknowledgments | p. xi |
Terminology of Intensive Diabetes Management | p. xii |
Rationale for and Physiological Basis of Intensive Diabetes Management | p. 1 |
Highlights | p. 2 |
Intensive Diabetes Management | p. 5 |
Physiological Basis of Intensive Management Methods | p. 7 |
Normal Fuel Metabolism | p. 7 |
Regulation of Fuel Metabolism | p. 9 |
Implications for Therapy | p. 10 |
The Team Approach | p. 15 |
Highlights | p. 16 |
Concept of Team Management | p. 18 |
Integrated Diabetes Management Team | p. 20 |
Role Definition | p. 22 |
Team Communication | p. 24 |
Functional Considerations | p. 25 |
Diabetes Self-Management Education | p. 29 |
Highlights | p. 30 |
Integration of the Team Approach | p. 31 |
Diabetes Continuing Education | p. 32 |
Assessment | p. 32 |
Instruction | p. 34 |
Environment | p. 34 |
Planning | p. 34 |
Content | p. 35 |
Sequencing of Classes | p. 37 |
Approaches/Strategies | p. 37 |
Motivation and Support | p. 39 |
Action Planning | p. 39 |
Evaluation | p. 40 |
Documentation | p. 41 |
Conclusion | p. 41 |
Psychosocial Issues | p. 43 |
Highlights | p. 44 |
Assessing Patient Suitability for Intensification | p. 46 |
Practicing Behavior | p. 46 |
Psychological Status and Psychosocial Support System | p. 48 |
The Individual | p. 49 |
Assessing the Effect of Stress on Glycemic Control | p. 50 |
The Family System | p. 51 |
Assessing Coping Skills | p. 52 |
Assessment of Diabetes-Related Coping | p. 52 |
Identifying Psychosocial Resources | p. 54 |
Supporting and Maintaining Patients' Behavior Changes | p. 55 |
Adoption of New Therapies and Therapeutic Modalities | p. 56 |
Helping Patients with Long-Term Adherence | p. 57 |
Lifestyle Changes | p. 59 |
Potential Adverse Psychological Outcomes of Treatment | p. 61 |
Depression | p. 61 |
Eating and Body Image Disorders | p. 62 |
Fear of Hypoglycemia | p. 63 |
Needle Phobia | p. 64 |
Helping Patients Deal with Complications | p. 65 |
Conclusion | p. 66 |
Patient Selection and Goals of Therapy | p. 69 |
Highlights | p. 70 |
Patient Selection | p. 71 |
Patients with Type 1 Diabetes | p. 73 |
Patients with Type 2 Diabetes | p. 74 |
Goals of Therapy | p. 75 |
Glycemic Goals | p. 76 |
Modifying Glycemic Goals | p. 78 |
Weighing Benefits and Risks in Type 2 Diabetes | p. 79 |
Conclusion | p. 79 |
Multiple-Component Insulin Regimens | p. 85 |
Highlights | p. 86 |
Insulin Pharmacology | p. 88 |
Insulin Timing and Action | p. 88 |
Stability of Insulins | p. 90 |
Insulin Absorption | p. 91 |
Insulin Regimens | p. 93 |
Multiple-Component Insulin Regimens: General Points | p. 93 |
Specific Flexible Multiple-Component Insulin Regimens | p. 96 |
Other Insulin Regimens | p. 99 |
Insulin Dose and Distribution | p. 99 |
Initial Insulin Doses | p. 99 |
Insulin Dose Distribution | p. 100 |
Insulin Adjustments | p. 100 |
Acute Adjustments | p. 100 |
Pattern Adjustments | p. 101 |
Injection Devices | p. 105 |
Conclusion | p. 105 |
Insulin Infusion Pump Therapy | p. 109 |
Highlights | p. 110 |
Benefits of CSII | p. 115 |
Initial Dosage Calculations for Insulin Pump Therapy | p. 116 |
Basal Insulin Dosage | p. 117 |
Bolus Insulin Dosage | p. 118 |
Insulin Dosage Adjustments | p. 120 |
Diet | p. 120 |
Exercise | p. 121 |
Illness | p. 121 |
Risks of CSH | p. 122 |
Skin Infection | p. 122 |
Unexplained Hyperglycemia and Ketoacidosis | p. 124 |
Hypoglycemia | p. 126 |
Wearing the Pump | p. 127 |
Patient Education for CSII | p. 129 |
Sensor Augmented Pump Therapy | p. 131 |
The Future | p. 132 |
Summary and Conclusion | p. 133 |
Monitoring | p. 137 |
Highlights | p. 138 |
Monitoring by the Patient | p. 139 |
Blood Glucose | p. 139 |
Ketone Monitoring | p. 140 |
Record Keeping | p. 141 |
Monitoring by the Health Care Team | p. 142 |
A1C - Estimated Average Glucose | p. 143 |
Real-Time Continuous Glucose Monitoring | p. 144 |
Monitoring for Long-Term Complications | p. 1145 |
Retinal Examinations | p. 145 |
Lipid Screening | p. 145 |
Blood Pressure | p. 146 |
Urinary Albumin Screening | p. 146 |
Foot Examinations | p. 147 |
Nutrition Management | p. 149 |
Highlights | p. 150 |
Goals of MNT | p. 152 |
Target Nutrition Recommendations | p. 153 |
Strategies for Type 1 Diabetes | p. 158 |
Strategies for Type 2 Diabetes | p. 159 |
Glucose Monitoring and the Nutritional Plan | p. 162 |
Blood Glucose Monitoring | p. 162 |
Continuous Glucose Monitoring | p. 163 |
Hypoglycemia | p. 164 |
Omitting or Delaying Planned Meals or Snacks | p. 164 |
Inappropriate Timing of Insulin Relative to Meals | p. 165 |
Imbalance Between Food and Meal-Related Insulin Dose | p. 166 |
Inadequate Food Supplementation for Exercise | p. 166 |
Consuming Alcohol on an Empty Stomach | p. 167 |
Oral Treatment of Hypoglycemia | p. 169 |
Facilitating Nutrition Self-Management | p. 169 |
Meal-Planning Approaches for Intensified Management | p. 170 |
Carbohydrate Counting | p. 170 |
Weight Gain Associated with Intensive Management | p. 171 |
Prevention | p. 172 |
Index | p. 175 |
Table of Contents provided by Ingram. All Rights Reserved. |
The New copy of this book will include any supplemental materials advertised. Please check the title of the book to determine if it should include any access cards, study guides, lab manuals, CDs, etc.
The Used, Rental and eBook copies of this book are not guaranteed to include any supplemental materials. Typically, only the book itself is included. This is true even if the title states it includes any access cards, study guides, lab manuals, CDs, etc.